Data Show That Net Drug Prices Fell, Surprisingly Thanks To Inflation


Stat reports on an analysis that shows even though drugmakers bumped wholesale prices 4.8% in the third quarter — more than in the same period last year — background inflation meant in net those prices fell by 3.1%. Also: AbbVie’s lobbying, pulse oximeter fixes, another Alzheimer’s treatment, and more.


Stat:
Inflation Caused Another Big Drop In Net Drug Prices, Analysis Finds


Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drugmakers increased their wholesale prices by 4.8% in the third quarter this year, up slightly from 4.2% a year earlier and 4.9% in the previous quarter. But when accounting for inflation, wholesale prices fell by 3.1%, and inflationary pressures are likely to push wholesale prices still higher. (Silverman, 12/15)

In other pharmaceutical news —


Stat:
To Fix Pulse Oximeters, The FDA Asked This Lab To Find Answers


The discovery that fingertip oxygen-measuring devices might contribute to health disparities because they appear to work less well on patients with darker skin has roiled the world of pulse oximetry, a $2 billion industry that now faces stricter regulations and pressure to address bias in the development and testing of its devices. (McFarling, 12/16)


Reuters:
Global Stockpile Of Cholera Vaccines ‘Empty Or Extremely Low’ – WHO 


A World Health Organization official said on Friday that the global stockpile of cholera vaccines it helps manage is “currently empty or extremely low” amid a resurgence of the disease around the world. The U.N. health agency says there are around 30 countries around the world that have reported cholera outbreaks this year which is about a third higher than a typical year. (12/16)

In research updates —


This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.



Source link

Ozinize
Logo
Shopping cart